{"name": "Auris Medical",
 "permalink": "auris-medical",
 "crunchbase_url": "http://www.crunchbase.com/company/auris-medical",
 "homepage_url": "http://www.aurismedical.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": 4,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "ear@aurismedical.com",
 "phone_number": "41-(0)61-201-13-50",
 "description": "",
 "created_at": "Sat Dec 19 12:18:25 UTC 2009",
 "updated_at": "Wed Apr 17 09:39:22 UTC 2013",
 "overview": "\u003Cp\u003EAuris Medical is dedicated to the development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders. They aim to protect people against hearing loss from various sources and to finally bring relief to people suffering \nfrom tinnitus.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       49],
      "assets/images/resized/0007/0431/70431v1-max-150x150.jpg"],
     [[250,
       83],
      "assets/images/resized/0007/0431/70431v1-max-250x250.jpg"],
     [[262,
       87],
      "assets/images/resized/0007/0431/70431v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$60.7M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.aurismedical.com/p/news/news_16.php?lg=en",
    "source_description": "Auris Medical completes Series B financing round",
    "raised_amount": 10080000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 2,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "IDInvest Partners",
         "permalink": "agf-private-equity",
         "image":
          {"available_sizes":
            [[[140,
               60],
              "assets/images/resized/0000/3772/3772v3-max-150x150.png"],
             [[140,
               60],
              "assets/images/resized/0000/3772/3772v3-max-250x250.png"],
             [[140,
               60],
              "assets/images/resized/0000/3772/3772v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ZKB Pharma Vision Fund",
         "permalink": "zkb-pharma-vision-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lacuna",
         "permalink": "lacuna-ag",
         "image":
          {"available_sizes":
            [[[150,
               90],
              "assets/images/resized/0006/1569/61569v3-max-150x150.png"],
             [[167,
               101],
              "assets/images/resized/0006/1569/61569v3-max-250x250.png"],
             [[167,
               101],
              "assets/images/resized/0006/1569/61569v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/story/swiss-biotech-raises-506m-further-hearing-loss-drugs/2013-04-16?utm_source=rss\u0026utm_medium=rss",
    "source_description": "Swiss biotech raises $50.6M to further hearing-loss drugs",
    "raised_amount": 50600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Partners",
         "permalink": "sofinnova-partners",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/4451/44451v1-max-150x150.jpg"],
             [[250,
               33],
              "assets/images/resized/0004/4451/44451v1-max-250x250.jpg"],
             [[321,
               43],
              "assets/images/resized/0004/4451/44451v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Aeschenvorstadt 37",
    "address2": "",
    "zip_code": "4051",
    "city": "Basel",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        93],
       "assets/images/resized/0007/0432/70432v1-max-150x150.jpg"],
      [[250,
        155],
       "assets/images/resized/0007/0432/70432v1-max-250x250.jpg"],
      [[450,
        280],
       "assets/images/resized/0007/0432/70432v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}